Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medicamenta Ecuatoriana is a leading pharmaceutical company in Ecuador and a key subsidiary of the Adium Pharma group. The company specializes in the commercialization, distribution, and marketing of high-complexity pharmaceutical products across various therapeutic areas, including oncology, hematology, cardiology, and rare diseases. Medicamenta serves as a strategic partner for several global multinational pharmaceutical companies, facilitating the entry of innovative treatments into the Ecuadorian market. With a robust infrastructure and extensive regulatory expertise, the company plays a vital role in the local healthcare ecosystem by providing access to specialized medicine. Its portfolio includes a mix of proprietary products and licensed therapies from international partners.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medicamenta Ecuatoriana.